SERPINC1 and major depressive disorder: As reported by Stelzhammer et al., compared to baseline levels, ATIII in MDD patients increased significantly after first ECT treatment; however, this was identified by liquid-chromatography mass spectrometry and not in combination with multiplex immunoassay (37).